AbbVie Future Growth
Future criteria checks 5/6
AbbVie is forecast to grow earnings and revenue by 25.5% and 5.7% per annum respectively. EPS is expected to grow by 25.8% per annum. Return on equity is forecast to be 170.5% in 3 years.
Key information
25.5%
Earnings growth rate
25.8%
EPS growth rate
Biotechs earnings growth | 0% |
Revenue growth rate | 5.7% |
Future return on equity | 170.5% |
Analyst coverage | Good |
Last updated | 12 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 62,748 | 14,004 | 26,704 | 26,342 | 24 |
12/31/2025 | 58,628 | 11,429 | 25,127 | 24,193 | 26 |
12/31/2024 | 55,714 | 8,844 | 15,484 | 19,657 | 23 |
6/30/2024 | 55,000 | 5,298 | 17,780 | 18,638 | N/A |
3/31/2024 | 54,403 | 5,951 | 21,891 | 22,686 | N/A |
12/31/2023 | 54,318 | 4,820 | 22,062 | 22,839 | N/A |
9/30/2023 | 55,138 | 6,470 | 24,729 | 25,514 | N/A |
6/30/2023 | 56,023 | 8,635 | 24,799 | 25,542 | N/A |
3/31/2023 | 56,741 | 7,535 | 23,520 | 24,228 | N/A |
12/31/2022 | 58,054 | 11,782 | 24,248 | 24,943 | N/A |
9/30/2022 | 57,819 | 13,343 | 21,921 | 22,590 | N/A |
6/30/2022 | 57,349 | 12,569 | 22,214 | 22,923 | N/A |
3/31/2022 | 56,725 | 12,407 | 22,047 | 22,808 | N/A |
12/31/2021 | 56,197 | 11,468 | 21,990 | 22,777 | N/A |
9/30/2021 | 55,169 | 7,465 | 21,677 | 22,556 | N/A |
6/30/2021 | 53,729 | 6,599 | 19,572 | 20,451 | N/A |
3/31/2021 | 50,195 | 5,092 | 17,789 | 18,650 | N/A |
12/31/2020 | 45,804 | 4,556 | 16,790 | 17,588 | N/A |
9/30/2020 | 40,650 | 7,324 | 15,327 | 16,009 | N/A |
6/30/2020 | 36,227 | 6,906 | 14,115 | 14,734 | N/A |
3/31/2020 | 34,057 | 8,395 | 13,552 | 14,122 | N/A |
12/31/2019 | 33,266 | 7,842 | 12,772 | 13,324 | N/A |
9/30/2019 | 32,867 | 3,232 | 12,929 | 13,441 | N/A |
6/30/2019 | 32,624 | 4,093 | 12,770 | 13,410 | N/A |
3/31/2019 | 32,647 | 5,333 | 13,173 | 13,799 | N/A |
12/31/2018 | 32,753 | 5,657 | 12,789 | 13,427 | N/A |
9/30/2018 | 32,187 | 7,531 | 11,922 | 12,619 | N/A |
6/30/2018 | 30,946 | 6,419 | 10,825 | 11,366 | N/A |
3/31/2018 | 29,612 | 6,352 | N/A | 10,503 | N/A |
12/31/2017 | 28,216 | 5,283 | N/A | 9,960 | N/A |
9/30/2017 | 27,273 | 6,615 | N/A | 8,917 | N/A |
6/30/2017 | 26,710 | 6,582 | N/A | 7,100 | N/A |
3/31/2017 | 26,218 | 6,278 | N/A | 7,015 | N/A |
12/31/2016 | 25,638 | 5,923 | N/A | 7,041 | N/A |
9/30/2016 | 25,242 | 6,048 | N/A | 7,463 | N/A |
6/30/2016 | 24,754 | 5,690 | N/A | 8,164 | N/A |
3/31/2016 | 23,777 | 5,448 | N/A | 8,078 | N/A |
12/31/2015 | 22,859 | 5,118 | N/A | 7,535 | N/A |
9/30/2015 | 21,911 | 2,790 | N/A | 4,994 | N/A |
6/30/2015 | 20,986 | 2,064 | N/A | 4,625 | N/A |
3/31/2015 | 20,437 | 1,802 | N/A | 4,510 | N/A |
12/31/2014 | 19,960 | 1,765 | N/A | 3,549 | N/A |
9/30/2014 | 19,619 | 3,686 | N/A | 5,372 | N/A |
6/30/2014 | 19,258 | 4,144 | N/A | 5,384 | N/A |
3/31/2014 | 19,024 | 4,114 | N/A | 5,704 | N/A |
12/31/2013 | 18,790 | 4,102 | N/A | 6,267 | N/A |
9/30/2013 | 18,885 | 4,540 | N/A | 5,963 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ABBVCL's forecast earnings growth (25.5% per year) is above the savings rate (5.5%).
Earnings vs Market: ABBVCL's earnings (25.5% per year) are forecast to grow faster than the CL market (16.8% per year).
High Growth Earnings: ABBVCL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ABBVCL's revenue (5.7% per year) is forecast to grow faster than the CL market (5.1% per year).
High Growth Revenue: ABBVCL's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ABBVCL's Return on Equity is forecast to be very high in 3 years time (170.5%).